For mouse Treg-suppression assays, CD4+CD25hi Tregs in tumor cell suspensions were sorted into KLRG1+ or KLRG1- cells and cultured at 1:2, 1:4, and 1:8 ratios with Carboxyfluorescein diacetate succinimidyl ester (CFSE)-labelled CD4+CD25- cells (0.25×105) isolated from the spleen of the same mouse. T cell–depleted, mitomycin C–treated splenocytes (0.25×105) were added as antigen presenting cells (APCs) and cultures were stimulated with soluble anti-CD3 (clone 2C11, ebioscience) at 0.5 µg/ml concentration for 3 days.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.